Skip to content

Undoing Addiction In The Brain's Reward Sector

Sophie Rovner

Chemical & Engineering News January 24, 2005 DOI: 10.1021/cen-v083n004.p009a (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Experimental study Peer reviewed
Population Rodents (rats)
Intervention Ibogaine
Topics Addiction
Keywords Citation Undoing Social media Icon Library science World wide web Psychoanalysis
Key findings Ibogaine reduces ethanol consumption and limits relapse effects after alcohol withdrawal in rats.

Abstract

New treatments for addiction could result from studies of ibogaine, an alkaloid derived from a West African shrub. Animal tests and anecdotal evidence in humans have indicated that ibogaine reduces cravings for alcohol and other drugs of abuse. Now, researchers at the University of California, San Francisco, have confirmed these findings in rodents and determined that ibogaine interacts with the brain's reward circuits. Ibogaine, which has hallucinogenic and neurotoxic side effects, has not been approved by the Food & Drug Administration. But some clinicians outside the U.S. use ibogaine to limit patients' withdrawal symptoms and craving for alcohol and other drugs, UCSF reports. Neuroscientists Dorit Ron and Patricia H. Janak and colleagues now provide evidence that backs the clinicians' faith in the compound [ J. Neurosci., 25, 619 (2005)]. The researchers confirmed previous findings that ibogaine reduces ethanol consumption in rats. They also showed that ibogaine limits relapse effects after alcohol withdrawal in rats. The ...

Comparable studies

Other preclinical and animal studies on addiction, most cited first.

Explore topics